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INVESTIGATION
N-terminal Sumoylation of Centromeric Histone H3
Variant Cse4 Regulates Its Proteolysis To Prevent
Mislocalization to Non-centromeric Chromatin
Kentaro Ohkuni,1 Reuben Levy-Myers,1,2 Jack Warren,1 Wei-Chun Au,1 Yoshimitsu Takahashi,1
Richard E. Baker,3 and Munira A. Basrai1,*
1Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland
20892, 2Biology Department, The College of William & Mary, Williamsburg, Virginia 23187, 3Department of Microbiology
and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts 01655
ABSTRACT Stringent regulation of cellular levels of evolutionarily conserved centromeric histone H3
variant (CENP-A in humans, CID in flies, Cse4 in yeast) prevents its mislocalization to non-centromeric
chromatin. Overexpression and mislocalization of CENP-A has been observed in cancers and leads to
aneuploidy in yeast, flies, and human cells. Ubiquitin-mediated proteolysis of Cse4 by E3 ligases such as
Psh1 and Sumo-Targeted Ubiquitin Ligase (STUbL) Slx5 prevent mislocalization of Cse4. Previously, we
identified Siz1 and Siz2 as the major E3 ligases for sumoylation of Cse4. In this study, we have identified
lysine 65 (K65) in Cse4 as a site that regulates sumoylation and ubiquitin-mediated proteolysis of Cse4 by
Slx5. Strains expressing cse4 K65R exhibit reduced levels of sumoylated and ubiquitinated Cse4 in vivo.
Furthermore, co-immunoprecipitation experiments reveal reduced interaction of cse4 K65R with Slx5, lead-
ing to increased stability and mislocalization of cse4 K65R under normal physiological conditions. Based on
the increased stability of cse4 K65R in psh1Δ strains but not in slx5Δ strains, we conclude that Slx5 targets
sumoylated Cse4 K65 for ubiquitination-mediated proteolysis independent of Psh1. In summary, we have
identified and characterized the physiological role of Cse4 K65 in sumoylation, ubiquitin-mediated pro-
teolysis, and localization of Cse4 for genome stability.
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Evolutionarily conserved centromeric histone H3, CENP-A (Cse4 in
Saccharomyces cerevisiae, Cnp1 in Schizosaccharomyces pombe, CID in
Drosophila, and CENP-A in humans), is essential for faithful chromo-
some segregation. Overexpression of Cse4, CID, and CENP-A leads to
its mislocalization to non-centromeric regions and contributes to an-
euploidy in yeast, flies, and human cells, respectively (Heun et al. 2006;
Moreno-Moreno et al. 2006; Collins et al. 2004; Au et al. 2008; Shrestha
et al. 2017). Overexpression and mislocalization of CENP-A, which is
observed in many cancers, is associated with poor prognosis and in-
creased invasiveness (Tomonaga et al. 2003; Amato et al. 2009; Hu et al.
2010; Li et al. 2011; Wu et al. 2012; Lacoste et al. 2014; Athwal et al.
2015; Sun et al. 2016). Hence, characterization of pathways that regu-
late cellular levels of CENP-A and its homologs will help us to un-
derstand how overexpression and mislocalization of CENP-A
contributes to tumorigenesis in human cells.
In budding yeast, ubiquitin-mediated proteolysis of Cse4 has been
shown to regulate cellular levels of Cse4 and this prevents its misloc-
alization to non-centromeric regions (Collins et al. 2004). Proteolysis
of Cse4 is regulated by several proteins: Psh1 (E3 ubiquitin ligase),
Doa1 (WD-repeat protein), Fpr3 (proline isomerase), Ubp8 (ubiquitin
protease), Rcy1 (F-box protein), and Ubr1 (E3 ubiquitin ligase)
(Hewawasam et al. 2010; Ranjitkar et al. 2010; Au et al. 2013;
Ohkuni et al. 2014; Canzonetta et al. 2015; Cheng et al. 2016; Cheng
et al. 2017). Psh1-mediated proteolysis of Cse4 is regulated by its in-
teraction with Spt16, a component of the FACT (facilitates chromatin
transcription/transactions) complex, and casein kinase 2 (CK2) (Deyter
and Biggins 2014; Hewawasam et al. 2014). Even though Psh1 interacts
with the CENP-A targeting domain (CATD) and ubiquitinates lysine
(K) residues (K131, K155, K163, and K172) in the C-terminus of Cse4
(Hewawasam et al. 2010; Ranjitkar et al. 2010), several observations
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support an important role of the N-terminus of Cse4 for regulating its
ubiquitin-mediated proteolysis. For example, ubiquitination of cse4
Δ129 (a deletion of the entire N-terminus of Cse4) is barely detectable
(Au et al. 2013). The stability of cse4 KC, where all K in the N-terminus
of Cse4 aremutated to arginine, is at least three-fold higher than that of
wild-type Cse4 (Au et al. 2013). Furthermore, the stability of cse4 KC is
at least four-fold higher than that of cse4 CK, where all K in the
C-terminus of Cse4 aremutated to arginine (Au et al. 2013). Proteolysis
defects in N-terminus Cse4 mutants contribute to chromosome loss, as
strains expressing cse4 KC exhibit a four-fold increase in chromosome
segregation defects when compared to cse4 CK strains (Au et al. 2013).
These results indicate that ubiquitination and interaction of Psh1 with
the C-terminus of Cse4 is not sufficient for Cse4 ubiquitin-mediated
proteolysis. Studies with fission yeast have also shown that the
N-terminus of Cnp1 mediates ubiquitin-mediated proteolysis of
Cnp1 to prevent its mislocalization to non-centromeric chromatin
(Gonzalez et al. 2014).
In addition to ubiquitination, we have recently reported that Cse4 is
sumoylated by the small ubiquitin-related modifier (SUMO) E3 ligases
Siz1 and Siz2 and that SUMO modification of Cse4 regulates its pro-
teolysis (Ohkuni et al. 2016). We showed that slx5Δ strains exhibit
defects in Cse4 proteolysis and localization that are independent of
Psh1. Slx5 is a SUMO-targeted ubiquitin ligase which regulates many
substrates with diverse biological functions such as transcription and
maintaining genome stability. Slx5 associates with centromeric chro-
matin, and slx5Δ strains exhibit aneuploidy, spindle mispositioning,
and aberrant spindle kinetics (van de Pasch et al. 2013). Given the
multiplicity of Slx5 substrates, it is possible that the defect in Cse4
proteolysis in slx5Δ strains may be indirect due to defects in post-
translational modifications of other substrates. Hence, we sought to
identify sumoylation sites in the N-terminus of Cse4 and investigated
how the interaction of Slx5 with sumoylated Cse4 regulates its pro-
teolysis and localization. Here we report the identification of K65
in Cse4 as a site that regulates sumoylation and show that Slx5-mediated
ubiquitination of Cse4K65 prevents itsmislocalization to non-centromeric
regions for genome stability.
MATERIALS AND METHODS
Yeast strains and plasmids
Table 1 and 2 describe the genotype of yeast strains and plasmids used
for this study, respectively. Yeast cells were grown in rich (YPD: 1%
yeast extract, 2% bacto-peptone, 2% glucose) or synthetic complete
(SC) media containing 2% glucose, or 2% raffinose, or 2% raffinose +
2% galactose.
Cell lysate preparation for pull down assays and
coimmunoprecipitation (co-IP)
For pull down assays and immunoprecipitation, cell lysates were pre-
pared as follows. 50 OD600 of logarithmically growing cells were pel-
leted, rinsed with sterile water, and suspended in 0.5 ml of guanidine
buffer (0.1 M Tris-HCl at pH 8.0, 6.0 M guanidine chloride, 0.5 M
NaCl) for sumoylation assay, or Ub lysis buffer (20 mM Na2HPO4,
20 mM NaH2PO4, 50 mM NaF, 5 mM tetra-sodium pyrophos-
phate, 10 mM beta-glycerophosphate, 2 mM EDTA, 1 mM DTT,
1% NP-40, 1 mM phenylmethylsulfonyl fluoride (PMSF), 5 mM
N-ethylmaleimide (NEM), 1x protease inhibitor cocktail (Sigma,
P8215)) for ubiquitin pull down assay, or IP lysis buffer (50 mM
Tris-HCl at pH 8.0, 5 mM EDTA, 1% TritonX-100, 150 mM NaCl,
50 mM NaF, 10 mM b-glycerophosphate, 1 mM PMSF, 1x protease
inhibitor cocktail) for coimmunoprecipitation. Cells were homoge-
nized with 0.5 mm diameter glass beads or Matrix C (MP Biomedicals)
n Table 1 S. cerevisiae stains used in this study
Strains Parent Genotype Reference
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems
BY4742 MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Open Biosystems
YMB9470 BY4741/BY4742 MATa cse4Δ::kanMX6 [pRS415-6His-3HA-CSE4] This study
YMB9471 BY4741/BY4742 MATa cse4Δ::kanMX6 psh1Δ::kanMX6 [pRS415-6His-3HA-CSE4] This study
YMB9472 BY4741/BY4742 MATa cse4Δ::kanMX6 slx5Δ::kanMX6 [pRS415-6His-3HA-CSE4] This study
YMB9547 BY4741/BY4742 MATa cse4Δ::kanMX6 [pRS415-6His-3HA-cse4 K65R] This study
YMB9548 BY4741/BY4742 MATa cse4Δ::kanMX6 psh1Δ::kanMX6 [pRS415-6His-3HA-cse4 K65R] This study
YMB9549 BY4741/BY4742 MATa cse4Δ::kanMX6 slx5Δ::kanMX6 [pRS415-6His-3HA-cse4 K65R] This study
YMB9694 BY4741 MATa SLX5-Myc:kanMX6 This study
YPH1018 MATa ura3-52 lys2-801 ade2-101 trp1Δ63 his3Δ200 leu2Δ1
CFIII (CEN3L.YPH278) HIS3 SUP11
P. Hieter
n Table 2 Plasmids used in this study
Plasmid Relevant characteristics Reference
pYES2 Vector (pGAL, 2m, URA3) (Boeckmann et al. 2013)
pMB433 Vector (p426-pGAL1, 2m, URA3) (Mumberg et al. 1994)
pMB1344 pYES2-pGAL-8His-HA-cse4 16KR (2m, URA3) (Ohkuni et al. 2016)
pMB1345 pYES2-pGAL-8His-HA-CSE4 (2m, URA3) (Ohkuni et al. 2016)
pMB1458 pMB433-pGAL-6His-3HA-CSE4 (2m, URA3) (Au et al. 2013)
pMB1597 pMB433-pGAL-3HA-CSE4 (2m, URA3) (Ohkuni et al. 2016)
pMB1725 pRS415-6His-3HA-CSE4 (CEN, LEU2) This study
pMB1749 pRS415-6His-3HA-cse4 K65R (CEN, LEU2) This study
pMB1762 pYES2-pGAL-8His-HA-cse4 K65R (2m, URA3) This study
pMB1791 pMB433-pGAL-6His-3HA-cse4 K65R (2m, URA3) This study
pMB1814 pMB433-pGAL-3HA-cse4 K65R (2m, URA3) This study
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using a bead beater (MP Biomedicals, FastPrep-24 5G). Cell lysates
were clarified by centrifugation at 6,000 rpm for 5 min and protein
concentration was determined using a DC protein assay kit (Bio-Rad).
Samples containing equal amounts of protein were brought to a total
volume of 1 ml with appropriate buffer.
Sumoylation assay
In vivo sumoylation was assayed in crude yeast extracts using Ni-NTA
agarose beads to pull down His-HA-tagged Cse4 as described previ-
ously (Ohkuni et al. 2015). Cell lysates were incubated with 100 ml of
Ni-NTA superflow beads (Qiagen, 30430) overnight at 4. After being
washed with guanidine buffer one time andwith breaking buffer (0.1M
Tris-HCl at pH 8.0, 20% glycerol, 1 mM PMSF) four times, beads were
incubated with 2x Laemmli buffer including imidazole at 100 for
10 min. The protein samples were analyzed by SDS-PAGE and West-
ern Blotting.
Ubiquitin pull down assay
Ubiquitin-pull down assay was performed as described previously (Au
et al. 2013). Cell lysates were incubated with 25ml of tandem ubiquitin-
binding entities Agarose-TUBE1 (LifeSensors, Inc. UM401) overnight
at 4. After being washed with TBS-T (20 mM Tris-HCl at pH 7.5,
150 mMNaCl, 0.1% Tween20) three times, beads were incubated with
2x Laemmli buffer at 100 for 5 min. The protein samples were ana-
lyzed by SDS-PAGE and Western Blotting.
Coimmunoprecipitation (Co-IP)
Cell lysates were incubated with 25 ml of Anti-HA-Agarose antibody
(Sigma, A2095) overnight at 4. After being washed with IP lysis buffer
three times, beads were incubated with 2x Laemmli buffer at 100 for
5 min. The protein samples were analyzed by SDS-PAGE andWestern
Blotting.
Protein stability assay
Protein stability assayswere performed as described previously (Ohkuni
et al. 2016). Logarithmically growing cells in YPD were treated with
cycloheximide (CHX) (20mg/ml). Protein extracts were prepared from
cells at the indicated time points and levels of Cse4 were quantitated by
western blot analysis. Multiple independent measurements were made,
and means are given on the applicable figures6 the standard error of
the mean with the number of replicates given in parentheses. Statistical
significance was assessed by one-way ANOVA (P = 0.0075) with se-
lected pairwise post hoc tests. Bonferroni correction was applied to
adjust P values for multiple comparisons.
SDS-PAGE and Western Blotting
SDS-PAGE was performed using 4–12% Bis-Tris gels (Novex). After
running the gels, proteins were transferred onto nitrocellulose mem-
brane (VitaScientific, DBOC80014). Western blotting was performed
according to a standard protocol. SuperSignal West Pico Chemilumi-
nescent Substrate (Thermo Scientific, 34078), or SuperSignalWest Pico
PLUS Chemiluminescent Substrate (Thermo Scientific, 34580), or One
Component Chemiluminescent Substrate (Rockland, UniGlow-0100)
was used for the detection. Protein levels were quantified using Gene
Tools software (version 3.8.8.0) from SynGene (Frederick, MD) or
Image Lab software (version 6.0.0) from Bio-Rad Laboratories, Inc
(Hercules, CA). Antibodies were as follows: anti-HA (12CA5) mouse
(Roche, 11583816001), anti-HA rabbit (Sigma, H6908), anti-c-Myc (A-
14) (Santa Cruz Biotechnology, sc-789), anti-Smt3 (y-84) (Santa Cruz
Biotechnology, sc-28649), and anti-Tub2 antibodies (Basrai labora-
tory). Anti-HA was used at a dilution from 1:1000 to 1:5000, and
anti-c-Myc, anti-Smt3, and anti-Tub2 were used at a dilution from
1:3000 to 1:5000. Secondary antibodies were ECL Mouse IgG,
Figure 1 Lysine 65 is a target of Cse4 sumoylation. (A) Wild-type strain
(BY4741) transformed with vector (pYES2), pGAL-8His-HA-CSE4
(pMB1345), pGAL-8His-HA-cse4 16KR (pMB1344), or pGAL-8His-HA-
cse4 K65R (pMB1762) was grown in raffinose/galactose (2%) for 4 hr to
induce expression of Cse4. Sumoylation of 8His-HA-Cse4 and non-
modified 8His-HA-Cse4 was assayed using protein extracts after pull
down on Ni-NTA beads followed by western blot analysis with anti-
Smt3 and anti-HA (Cse4) antibodies, respectively. At least three high
molecular weight bands of 8His-HA-Cse4 (arrows) were detected. In-
put samples were analyzed using anti-HA (Cse4) and anti-Tub2 anti-
bodies served as loading control for input. Asterisk shows nonspecific
sumoylated proteins that bind to beads. (B) Quantitation of sumoyla-
tion in arbitrary density units (normalized to non-modified Cse4
probed by anti-HA in pull down sample) determined in multiple ex-
periments. Statistical significance was assessed by one-way ANOVA
(P = 0.007) followed by all possible pairwise comparisons of the means
with Bonferroni correction. Error bars indicate standard deviation from
the mean.
Volume 8 April 2018 | Cse4 sumoylation regulates proteolysis | 1217
HRP-linked whole Ab (GE Healthcare Life Sciences, NA931V) or
ECL Rabbit IgG, HRP-linked whole Ab (GE Healthcare Life Sciences,
NA934V) at 1:5000 dilution.
Chromosome spreads
Chromosome spreads were performed as described previously (Crotti
and Basrai 2004; Collins et al. 2004) with some modifications. Cells
were grown in YPD logarithmically. 16B12 Mouse anti-HA antibody
(Covance, Babco; MMS-101P) was used as primary antibody at 1:2500
dilution. Cy3 conjugated Goat anti mouse (Jackson ImmunoResearch
Laboratories, Inc., 115165003) was used as secondary antibody at
1:5000 dilution. DNA was visualized by DAPI (4’,6-diamidino-2-
phenylindole) staining (1 mg/ml in phosphate-buffered saline)
mounted in antifade mountant (Molecular Probes, P36935). Cells
were examined under an Axioskop 2 (Zeiss) fluorescence microscope
equipped with a Plan-APOCHROMAT 100X (Zeiss) oil immersion
lens. Image acquisition and processing were performed with the IP
Lab version 3.9.9 r3 software (Scanalytics, Inc.).
Figure 3 K65R mutation in Cse4 contributes to reduced interaction
with Slx5. (A) Protein extracts were prepared from the indicated strains
grown in raffinose/galactose (2%) for 4 hr to induce expression of Cse4
and incubated with anti-HA agarose antibody. Samples were resolved
by SDS-PAGE and levels of Slx5 and Cse4 were detected by western
blot analysis with anti-Myc and anti-HA antibodies, respectively.
Isogenic yeast strains were: untagged (BY4741), or Slx5-Myc
(YMB9694) strain transformed with vector (pMB433), pGAL-3HA-
CSE4 (pMB1458), or pGAL-3HA-cse4 K65R (pMB1791). (B) Levels of
Slx5 (a-Myc, IP) after immunoprecipitation of 3HA-Cse4 were quanti-
fied in arbitrary density units after normalization to Cse4 levels in the IP
(a-HA, IP) in three independent experiments (with additional replicates
for 3HA-cse4 K65R). Statistical significance of the normalized values
was assessed by unpaired t-test. Error bars show standard deviation
from the mean.
Figure 2 Cse4 ubiquitination is reduced in a cse4 K65R mutant. (A)
Protein extracts were prepared from wild-type strain (BY4741) trans-
formed with vector (pMB433), pGAL-3HA-CSE4 (pMB1458), or pGAL-
3HA-cse4 K65R (pMB1791) grown in raffinose/galactose (2%) for 4 hr
to induce expression of Cse4. Agarose-TUBE1 was used to pull down
tandem ubiquitin binding entities and ubiquitination levels of Cse4
were detected by western blot analysis with anti-HA antibody. Input
samples were analyzed using anti-HA (Cse4) and anti-Tub2 antibodies.
Asterisk shows non-modified Cse4. (B) Quantitation of ubiquitination
in arbitrary density units (normalized to levels of Cse4 in input) was
determined in three independent trials (with additional replicates for
3HA-cse4 K65R). Statistical significance was assessed by unpaired
t-test. Error bars show standard deviation from the mean.
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Chromosome loss assay
Chromosome loss assays were performed as described previously
(Spencer et al. 1990; Au et al. 2008). Briefly, strains containing a non-
essential reporter chromosome were plated on synthetic defined me-
dium with limiting adenine plus 2% galactose/raffinose and incubated
at 30 for 5 days. Loss of the reporter chromosome results in red sectors
in an otherwise a white colony. Colonies that are at least half red in-
dicate loss of the reporter chromosome in the first cell division. At least
2,500 colonies were assayed from three individual transformants for
each strain.
Data availability
All strains and plasmids are available upon request. The authors state
that all data necessary for confirming the conclusions presented in the
article are represented fully within the article.
RESULTS
Cse4 K65 is a target of sumoylation
The consensus motifC-K-x-D/E (C is a hydrophobic residue, K is the
lysine to be conjugated to SUMO, x is any amino acid, D or E is an
acidic residue) is frequently found in sumoylated substrates (Sampson
et al. 2001; Rodriguez et al. 2001; Bernier-Villamor et al. 2002). We
identified lysine (K) 65 (64-SKSD-67) in the N-terminus of Cse4 and
K215/K216 (214-MKKD-217) in the C-terminus of Cse4 as potential
sumoylation sites. Given the importance of the Cse4 N-terminus in
ubiquitination and proteolysis (Au et al. 2013), we examined whether
Cse4 K65 is sumoylated in vivo and further characterized its role in
regulating proteolysis and localization of Cse4. We assayed the sumoy-
lation status of transiently overexpressed 8His-Hemagglutinin (HA)-
CSE4, 8His-HA-cse4 16KR (all K mutated to R), or 8His-HA-cse4
K65R (K65 mutated to R65). Pull down experiments were done using
Ni-NTA agarose beads, and SUMO-modified Cse4 species were de-
tected using anti-Smt3 antibody (Figure 1). At least three distinct
sumoylated Cse4 species were observed in wild-type cells (Figure 1A,
denoted by arrows), as previously described (Ohkuni et al. 2016). These
SUMO-modified species were not detected in strains expressing vector
alone or 8His-HA-cse4 16KR. Strains expressing 8His-HA-cse4 K65R
showed greatly reduced levels of Cse4 sumoylation even though similar
levels of Cse4 and cse4 K65R were pulled down (Figure 1A). Significant
reduction in sumoylation status was observed for cse4 K65R when
compared to Cse4 (P = 0.029), but not between cse4 K65R and cse4
16KR (P = 0.63) (Figure 1B). Taken together, our results suggest that
Cse4 K65 is a target of sumoylation.
Cse4 ubiquitination is reduced in a cse4 K65R mutant
The reduced sumoylation of cse4 K65R prompted us to investigate if
sumoylation of Cse4K65 affects the ubiquitination of Cse4.We assayed
Figure 4 Sumoylation of Cse4 K65
regulates its proteolysis and localiza-
tion under normal physiological con-
ditions. (A) Protein extracts from CSE4
(YMB9470) or cse4 K65R (YMB9547)
strain were prepared using logarithmi-
cally growing cells, treated with CHX
(20 mg/ml) for various time points.
Blots were probed with anti-HA
(Cse4) or anti-Tub2 (loading control)
antibody. A representative blot is
shown. Cse4 protein half-life (t1/2) is
reported as the mean 6 SEM of mul-
tiple biological repeats. The differ-
ence in t1/2 is statistically significant
(P = 0.013). See materials and
methods for details. (B) Kinetics of
turnover. The graph shows the per-
centage of Cse4 signals normalized
to Tub2 at the indicated time points
in wild-type and cse4 K65R mutant.
Error bars indicate standard devia-
tions of the means. (C) Chromosome
spreads of logarithmically-grown
wild-type (YMB9470) or cse4 K65R
(YMB9547) cells. DAPI (blue) and
a-HA (red) staining were used to visu-
alize DNA and Cse4 localization, re-
spectively. In wild-type strains, Cse4
is predominantly localized to one to
two kinetochore clusters. In mutant
strains, mislocalization of Cse4 is ob-
served as multiple foci or diffused lo-
calization throughout the nucleus. (D)
Quantification of Cse4 mislocalization in two independent experiments. The increased mislocalization observed for the cse4 K65R strain was
highly significant (P , 0.001) in both biological replicates (Chi-square test, N = 237, 237 and N = 251, 281 for wild-type and cse4 K65R,
respectively in replicate 1 and replicate 2).
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the level of ubiquitinated Cse4 by performing an affinity pull down assay
using agarose with tandem ubiquitin-binding entities (Ub+) from strains
transiently overexpressed either 3HA-CSE4 or 3HA-cse4 K65R (Figure 2).
A faster migrating species (Figure 2A, asterisk) was observed in all strains
expressing Cse4. These faster migrating Cse4 species were similar in size
to that in the input lanes. These species were also observed in experiments
with cse4 16KR mutant (Au et al. 2013). Since cse4 16KR cannot be
ubiquitinated, this faster migrating species represents unmodified
Cse4, which likely interacts with ubiquitinated proteins such as
canonical histones. Ubiquitinated Cse4 was detected as a laddering
pattern in wild-type cells expressing 3HA-CSE4 but was absent in
strains with vector alone (Figure 2A). However, reduced levels of
ubiquitination were observed in strains expressing 3HA-cse4 K65R
(Figure 2, A and B). The lack of a drastic reduction in the levels of
ubiquitinated cse4 K65R is not surprising given that the other fifteen
lysines can still be ubiquitinated. These results show that Cse4 K65
contributes to Cse4 ubiquitination.
Cse4 K65 is regulated by STUbL Slx5
We have previously shown that STUbL Slx5 interacts with Cse4 and
promotes its ubiquitin-mediated proteolysis (Ohkuni et al. 2016). Slx5
contains SUMO-interactingmotifs (SIMs), which interact with sumoy-
lated substrates (Xie et al. 2007; Xie et al. 2010). We reasoned
that reduced sumoylation and ubiquitination of cse4 K65R may
be due to reduced interaction of cse4 K65R with Slx5.
Co-immunoprecipitation (Co-IP) experiments were done using
strains co-expressing either 3HA-CSE4 or 3HA-cse4 K65R with
SLX5-Myc (Figure 3). Consistent with our previous results
(Ohkuni et al. 2016), immunoprecipitation with anti-HA showed
an interaction between wild-type Cse4 and Slx5 (Figure 3A). In
contrast, reduced interaction was observed between cse4 K65R
and Slx5 (Figure 3, A and B). Hence, we conclude that sumoylation
of Cse4 K65 contributes to its interaction with Slx5.
Sumoylation of Cse4 K65 regulates its proteolysis and
localization under normal physiological conditions
To determine if defects in sumoylation and ubiquitination of cse4 K65R
contribute to a defect in proteolysis of cse4 K65R, we performed protein
stability assays using cells expressing either CSE4 or cse4 K65R from its
endogenous promoter. Cells were grown logarithmically and then treated
with cycloheximide (CHX) to inhibit protein translation.Whole cell extracts
were assayed for Cse4 levels at different times after CHX treatment. Cse4
was rapidly degraded (t1/2 = 33.56 0.8 min) in wild-type strains, whereas
cse4 K65R was modestly stabilized (t1/2 = 50.86 6.1 min) (Figure 4, A and
B). These observations indicate that K65 of Cse4 regulates its proteolysis.
Previous studies have shown that defects in ubiquitin-mediated
proteolysis of Cse4 in slx5Δ and psh1Δ strains lead to mislocalization
of Cse4 to non-centromeric regions under normal physiological con-
ditions (Ohkuni et al. 2016). Therefore, we examined whether the in-
creased stability observed for cse4 K65R expressed from its own
promoter leads to mislocalization to non-centromeric regions. Chro-
mosome spreads were used to visualize localization of chromatin-
bound Cse4. In wild-type cells, Cse4 localization is usually restricted
to one or two foci, corresponding to kinetochore clusters (Figure 4, C
and D). In contrast, a higher incidence of multiple or diffuse cse4 K65R
foci were observed under the same condition (Figure 4, C and D). We
Figure 5 Cse4 K65 sumoylation
regulates its proteolysis by Slx5
in a Psh1-independent manner.
(A and C) Protein extracts were
prepared using logarithmically
growing cells, treated with CHX
(20 mg/ml) for various time
points. Blots were probed with
anti-HA (Cse4) or anti-Tub2
(loading control) antibody. A
representative blot is shown.
Cse4 protein half-lives (t1/2) are
reported as the mean 6 SEM
of multiple biological repeats.
The difference in t1/2 between
wild-type Cse4 and cse4 K65R
is statistically significant in the
psh1Δ strain (P = 0.043) but not
in the slx5Δ strain (P. 0.99). See
materials and methods for de-
tails. (B and D) Kinetics of turn-
over. The graph shows the
percentage of Cse4 signals nor-
malized to Tub2 at the indicated
time points in the indicated
strains. Error bars indicate stan-
dard deviations of the means.
(A) Strains analyzed were
YMB9470 (CSE4), YMB9472
(CSE4 slx5Δ), and YMB9549
(cse4 K65R slx5Δ). (C) Strains an-
alyzed were YMB9470 (CSE4),
YMB9471 (CSE4 psh1Δ), and
YMB9548 (cse4 K65R psh1Δ).
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conclude that ubiquitin-mediated proteolysis of Cse4 via sumoylation
of K65 prevents its mislocalization to non-centromeric chromatin.
Sumoylation of Cse4 K65 is required for Slx5-mediated
proteolysis independent of Psh1
Based on the reduced interaction of cse4 K65R with Slx5 (Figure 3), we
predicted that the stability of cse4 K65R would not differ significantly
from that of Cse4 in slx5Δ strains under normal physiological condi-
tions. In agreement with previous results (Ohkuni et al. 2016), pro-
tein stability assays showed that Cse4 was more stable in the slx5Δ strain
(t1/2= 43.0 6 6.5 min) when compared to the wild-type strain (t1/2=
33.56 0.8 min) (Figure 5, A and B). Consistent with our hypothesis,
the stability of cse4 K65R (t1/2= 43.56 2.7 min) was not significantly
different than that of Cse4 (t1/2 = 43.0 6 6.5 min) in the slx5Δ strain
(Figure 5, A and B).
We next analyzed the stability of Cse4 using a psh1Δ strain. Pro-
tein stability assays showed that Cse4 was more stable in a psh1Δ strain
(t1/2= 42.96 3.4 min) compared to that observed in a wild-type strain
(t1/2= 33.56 0.8 min) under normal physiological conditions (Figure 5,
C and D). The stability of cse4 K65R (t1/2 = 58.06 2.8 min) was much
higher than that of Cse4 (t1/2 = 42.9 6 3.4 min) in the psh1Δ strain
(Figure 5, C andD). Hence, we conclude that Slx5-mediated proteolysis
of Cse4 dependent on Cse4 K65 is independent of Psh1.
Sumoylation of Cse4 K65 regulates faithful
chromosome segregation
To determine the physiological consequence of mislocalized cse4 K65R
ongenome stability, weused a colony color assay tomeasure the loss of a
nonessential reporter chromosome. Previous studies have shown that
strains overexpressing cse4 16KR exhibit increased chromosome loss
compared to GAL-CSE4 (Au et al. 2008). However, no measurable
increase in chromosome loss was observed in cells expressing cse4
16KR from its native promoter (Au et al. 2008). Therefore, we mea-
sured chromosome loss using wild-type strain transformed with vector
alone, GAL-CSE4 and GAL-cse4 K65R. The GAL-cse4 K65R strain ex-
hibits 1.6-fold higher chromosome loss compared toGAL-CSE4 strains
(Figure 6, P, 0.001). These results show that sumoylation of Cse4 K65
regulates faithful chromosome segregation.
DISCUSSION
We have identified Cse4 K65 as a site that regulates its sumoylation and
showed that Cse4 sumoylation regulates its ubiquitin-mediated proteol-
ysis and localization for genome stability. Strains expressing cse4 K65R
exhibit defects in Cse4 sumoylation and ubiquitination and show re-
duced interaction of cse4 K65R with Slx5. Defects in proteolysis and
mislocalization of cse4 K65R to non-centromeric chromatin were ob-
served under normal physiological conditions. The increased stability of
cse4 K65R in psh1Δ strains but not in slx5Δ strains indicates that sumoy-
lation of Cse4 K65 regulates Slx5-mediated proteolysis, independently of
Psh1.We propose that sumoylation of Cse4 K65 promotes its interaction
with Slx5, and this is required for Slx5-mediated proteolysis of Cse4 to
prevent its mislocalization for faithful chromosome segregation.
Reduced Cse4 sumoylation observed for the cse4 K65R mutant sup-
ports the role of Cse4 K65 as a sumoylation site in the N-terminus of
Cse4. The defects in sumoylation and ubiquitination of cse4K65R are not
as severe as that observed for cse4 16KR. Furthermore, ubiquitination
defects of Cse4 are more pronounced in slx5Δ strains (Ohkuni et al.
2016), compared to that observed for cse4 K65R. These results suggest
that sumoylation and ubiquitination of other lysine residues of Cse4 or
other substrates of Slx5 also contribute to proteolysis of Cse4.
Our results show that Cse4 K65 is required for Slx5-mediated pro-
teolysis independent of Psh1. Several experimental findings support this
conclusion:1) reduced interactionofcse4K65RwithSlx5, 2)noadditional
proteolysis defects of cse4 K65R in slx5Δ strains, and 3) increased pro-
teolysis defects of cse4 K65R in psh1Δ strains. Our results are consistent
with previous studies which showed ubiquitination of K131, K155, K163
and K172, but not K65 of Cse4, by Psh1 (Hewawasam et al. 2010).
Studies to date have described multiple E3 ligases including Psh1, Slx5,
Ubr1, and Rcy1 (F-box protein in the SCF (Skp1-Cullin-F-box) complex) in
the proteolysis of overexpressed Cse4 (Cheng et al. 2017). We note that the
physiological consequence of defects in the Cse4 E3 ligases characterized to
date ismost apparentwhenCse4 is overexpressed.Wepropose that this type
of regulation ensures that levels of endogenously expressed Cse4 are main-
tained at a critical threshold for the essential role of Cse4 at centromeres.
In summary, our studies have identified and characterized the phys-
iological role ofCse4 sumoylation.Cse4K65 regulatesubiquitin-mediated
proteolysis by Slx5 to prevent mislocalization of Cse4 and is itself a likely
sumoylation target. Sumoylation of kinetochore proteins or proteins
required for sister chromatid cohesion and spindle assembly checkpoint
regulate faithful chromosome segregation (Eifler and Vertegaal 2015;
Mukhopadhyay and Dasso 2017). Deregulation of sumoylation machin-
ery causes severe defects in cell proliferation and genome stability and
promotes tumorigenesis (Eifler and Vertegaal 2015; Seeler and Dejean
2017). Unlike Psh1, Slx5 is evolutionarily conserved and the mammalian
ortholog RNF4 has been shown to regulate chromosome segregation
(van de Pasch et al. 2013). Since ubiquitination and sumoylation prevent
mislocalization of Cse4 for genome stability, it will be of interest to de-
termine if these post-translational modifications of CENP-A also prevent
its mislocalization to preserve genome stability in human cells.
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